RT @email@example.com: @firstname.lastname@example.org A4 Not to downplay the depth and seriousness of online discourse, but what is right in front of us often feels larger and more monumental than it is in hindsight. I take deep breaths, walk away to clear my head/heart, look for guidance in another venue. #engageMOOC
evidence based med Show more
Evidence based medicine sounds great but I am also aware that the deepest pockets belong to those who sell the drugs and are interested in selling more, not necessarily those who are looking for the right recommendation by systematically zooming into a treatment/therapeutic field. There will be a bias in which research questions are asked.
Limitations of the scientific literature need to communicated. But a critical eye and time is all you should need.
Hey is there a .@ feature on Mastodon to expose your @ toots to your followers? Or is the preferred way to do that by boosting you own toot?
I still have a gmail account but I'm slowly transitioning away from it (protonmail). I'd say my youTube subscriptions are the thing I am the least prepared to migrate away from. I'll probably always have some google account to maintain some involvement in that community although a lot of of the people I watch update their Patreon. I think I still use the youTube recommendations to find new content creators. (2/2)
My first cross boost from Twitter: I think conduct of interest disclosure is important: the ethos of the paper's rhetoric becomes easier to interpret. I'm always a bit leery when a big hubbub is made that the CNS journals have done something great. What would be great is a shift in their business model.
Tweet from david ropeik (@dropeik), at 2 Feb, 22:21
I am still interested in the ways bacteria coordinate action in complex environments, but I also think that the updating of the way we share research outputs is worth devoting a career to.